128 related articles for article (PubMed ID: 7542617)
1. Receptor-mediated transfer of pSV2CAT DNA to a human hepatoblastoma cell line HepG2 using asialofetuin-labeled cationic liposomes.
Hara T; Aramaki Y; Takada S; Koike K; Tsuchiya S
Gene; 1995 Jul; 159(2):167-74. PubMed ID: 7542617
[TBL] [Abstract][Full Text] [Related]
2. Receptor-mediated transfer of pSV2CAT DNA to mouse liver cells using asialofetuin-labeled liposomes.
Hara T; Aramaki Y; Takada S; Koike K; Tsuchiya S
Gene Ther; 1995 Dec; 2(10):784-8. PubMed ID: 8750019
[TBL] [Abstract][Full Text] [Related]
3. Effects of fusogenic and DNA-binding amphiphilic compounds on the receptor-mediated gene transfer into hepatic cells by asialofetuin-labeled liposomes.
Hara T; Kuwasawa H; Aramaki Y; Takada S; Koike K; Ishidate K; Kato H; Tsuchiya S
Biochim Biophys Acta; 1996 Jan; 1278(1):51-8. PubMed ID: 8611607
[TBL] [Abstract][Full Text] [Related]
4. Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asialofetuin-lipoplexes.
Arangoa MA; Düzgüneş N; Tros de Ilarduya C
Gene Ther; 2003 Jan; 10(1):5-14. PubMed ID: 12525832
[TBL] [Abstract][Full Text] [Related]
5. Efficient gene transfer to hepatoblastoma cells through asialoglycoprotein receptor and expression under the control of the cyclin A promoter.
Aramaki Y; Lee I; Arima H; Sakamoto T; Magami Y; Yoshimoto T; Moriyasu F; Mizuguchi J; Koyanagi Y; Nikaido T; Tsuchiya S
Biol Pharm Bull; 2003 Mar; 26(3):357-60. PubMed ID: 12612447
[TBL] [Abstract][Full Text] [Related]
6. Intracellular delivery of membrane-impermeable hydrophilic molecules to a hepatoblastoma cell line by asialoglycoprotein-labeled liposomes.
Yu HY; Lin JH
J Formos Med Assoc; 2000 Dec; 99(12):936-41. PubMed ID: 11155748
[TBL] [Abstract][Full Text] [Related]
7. Specific uptake of asialofetuin-tacked liposomes encapsulating interferon-gamma by human hepatoma cells and its inhibitory effect on hepatitis B virus replication.
Ishihara H; Hayashi Y; Hara T; Aramaki Y; Tsuchiya S; Koike K
Biochem Biophys Res Commun; 1991 Jan; 174(2):839-45. PubMed ID: 1704230
[TBL] [Abstract][Full Text] [Related]
8. Preparation of asialofetuin-labeled liposomes with encapsulated human interferon-gamma and their uptake by isolated rat hepatocytes.
Ishihara H; Hara T; Aramaki Y; Tsuchiya S; Hosoi K
Pharm Res; 1990 May; 7(5):542-6. PubMed ID: 1694992
[TBL] [Abstract][Full Text] [Related]
9. Liver targeting liposomes containing beta-sitosterol glucoside with regard to penetration-enhancing effect on HepG2 cells.
Kawano K; Nakamura K; Hayashi K; Nagai T; Takayama K; Maitani Y
Biol Pharm Bull; 2002 Jun; 25(6):766-70. PubMed ID: 12081144
[TBL] [Abstract][Full Text] [Related]
10. Receptor-mediated gene delivery to HepG2 cells by ternary assemblies containing cationic liposomes and cationized asialoorosomucoid.
Singh M; Kisoon N; Ariatti M
Drug Deliv; 2001; 8(1):29-34. PubMed ID: 11280441
[TBL] [Abstract][Full Text] [Related]
11. [Transfection and anti-HBV effect mediated by the hepatocytes-targeting cationic liposomes co-modified with beta-sitosterol-beta-D-glucoside and Brij 35].
Zhang Y; Qi XR; Gao Y; Wei L
Yao Xue Xue Bao; 2006 Nov; 41(11):1111-5. PubMed ID: 17262957
[TBL] [Abstract][Full Text] [Related]
12. Biotin-directed assembly of targeted modular lipoplexes and their transfection of human hepatoma cells in vitro.
Singh A; Ariatti M; Singh M; Hawtrey A; Naidoo R
Drug Deliv; 2010 Aug; 17(6):426-33. PubMed ID: 20469969
[TBL] [Abstract][Full Text] [Related]
13. Asialofetuin liposome-mediated human alpha1-antitrypsin gene transfer in vivo results in stationary long-term gene expression.
Dasí F; Benet M; Crespo J; Crespo A; Aliño SF
J Mol Med (Berl); 2001 May; 79(4):205-12. PubMed ID: 11409712
[TBL] [Abstract][Full Text] [Related]
14. Increased liver uptake of liposomes and improved targeting efficacy by labeling with asialofetuin in rodents.
Wu J; Liu P; Zhu JL; Maddukuri S; Zern MA
Hepatology; 1998 Mar; 27(3):772-8. PubMed ID: 9500706
[TBL] [Abstract][Full Text] [Related]
15. Specific incorporation of asialofetuin-labeled liposomes into hepatocytes through the action of galactose-binding protein.
Hara T; Aramaki Y; Tsuchiya S; Hosoi K; Okada A
Biopharm Drug Dispos; 1987; 8(4):327-39. PubMed ID: 2441770
[TBL] [Abstract][Full Text] [Related]
16. Novel gene delivery to liver cells using engineered virosomes.
Ramani K; Bora RS; Kumar M; Tyagi SK; Sarkar DP
FEBS Lett; 1997 Mar; 404(2-3):164-8. PubMed ID: 9119056
[TBL] [Abstract][Full Text] [Related]
17. Efficiency of liposomes surface-modified with soybean-derived sterylglucoside as a liver targeting carrier in HepG2 cells.
Maitani Y; Kawano K; Yamada K; Nagai T; Takayama K
J Control Release; 2001 Aug; 75(3):381-9. PubMed ID: 11489324
[TBL] [Abstract][Full Text] [Related]
18. Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes.
Kawakami S; Yamashita F; Nishikawa M; Takakura Y; Hashida M
Biochem Biophys Res Commun; 1998 Nov; 252(1):78-83. PubMed ID: 9813149
[TBL] [Abstract][Full Text] [Related]
19. Asialofetuin liposomes for receptor-mediated gene transfer into hepatic cells.
Aliño SF; Benet M; Dasí F; Crespo J
Methods Enzymol; 2003; 373():399-421. PubMed ID: 14714418
[No Abstract] [Full Text] [Related]
20. Metabolism of asialoglycoproteins in cultured rat hepatocytes: evidence for receptor mediated uptake and degradation which is not feed-back regulated.
Drevon CA; Tolleshaug H; Carlander B; Berg T
Int J Biochem; 1983; 15(6):827-33. PubMed ID: 6190689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
